Results 22,541-22,560 of 33,025 for speaker:Catherine Connolly
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: Please clarify that for me.
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: There were 11 cases preceding that of Ms Vicky Phelan?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: It has increased since then. My colleague on my right asked about the laboratories. Who is being sued in these 31 cases?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: Is that in each of them?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: In being.
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: What is the breakdown of the laboratories? I want to be clear about the laboratories. One is American but operates in Ireland. Is that correct?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: Is that Quest Diagnostics in half of these 31 cases?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: Is MedLab the one with the operation in Ireland?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: The HSE is also being sued. In all of the letters then, is it either one or both of these labs plus the HSE that is being sued?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: Is it correct that the HSE has adopted a new approach and that a paper will be sent in to the committee to clarify that?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: Yes, I do. Is Mr. Breen at liberty to tell us where the State Claims Agency stands with these cases in the context of hat new process?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: The State Claims Agency is, in effect, acting as an agent for the laboratories.
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: The agency will rely on its indemnities.
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: There are contracts with these laboratories. What contracts are in place in terms of time?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: What about Quest Diagnostics?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: The witnesses can come back with the precise date. Will the contract with Quest be up this year?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: That is this year.
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: What about MedLab Pathology?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: What are the plans for those contracts?
- Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)
Catherine Connolly: The new system being put in place will determine the type of lab to be sought.